Stock Market News

1 day FDA requires GSK and Pfizer vaccines to carry rare side effect warnings Investing.com

FDA requires GSK and Pfizer vaccines to carry rare side effect warnings.

Pfizer (PFE)

8 hours Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note Zacks

8 hours GSK, Pfizer RSV shots must warn about rare paralysis risk Fortune

14 hours Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha

2 days Why Pfizer (PFE) is a Top Value Stock for the Long-Term Zacks

2 days Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks

5 days Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

6 days Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

6 days Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

6 days Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

6 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

6 days The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

6 days Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

7 days Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

7 days Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

7 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

1 week Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

1 week 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

1 week Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

1 week Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

1 week Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

1 week Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

1 week Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

1 week Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

1 week NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

1 week 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

1 week Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

1 week SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

1 week Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

1 week Pfizer: One Of The Next Big AI Winners Seeking Alpha

2 weeks Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

2 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

2 weeks Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

2 weeks Better Income Stock: Pfizer or Altria Group? Yahoo Finance

2 weeks Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

2 weeks Should Value Investors Buy Pfizer (PFE) Stock? Zacks

2 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

2 weeks Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

3 weeks Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

3 weeks Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

3 weeks Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

3 weeks Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

3 weeks Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

3 weeks Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

3 weeks Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

3 weeks Final Trade: GOOG, SAIA, X, PFE YouTube

3 weeks Pfizer climbs 4% on 2025 outlook YouTube

3 weeks Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

3 weeks Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

3 weeks Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

3 weeks Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube